Literature DB >> 12719205

Central nervous system active medications and risk for fractures in older women.

Kristine E Ensrud1, Terri Blackwell, Carol M Mangione, Paula J Bowman, Douglas C Bauer, Ann Schwartz, Joseph T Hanlon, Michael C Nevitt, Mary A Whooley.   

Abstract

BACKGROUND: Use of central nervous system (CNS) active medications may increase the risk for fractures. Prior studies are limited by incomplete control of confounders.
METHODS: To determine whether use of CNS active medications, including benzodiazepines, antidepressants, anticonvulsants, and narcotics, increases fracture risk in elderly, community-dwelling women, we examined use of these 4 categories of medications in a cohort of 8127 older women and followed the participants prospectively for incident nonspine fractures, including hip fractures. Current use of CNS active medications was assessed by interview with verification of use from containers between 1992 and 1994 and between 1995 and 1996. Use was coded as a time-dependent variable. Incident nonspine fractures occurring after the initial medication assessment until May 31, 1999, were confirmed by radiographic reports.
RESULTS: During an average follow-up of 4.8 years, 1256 women (15%) experienced at least one nonspine fracture, including 288 (4%) with first hip fractures. Compared with nonusers, women taking narcotics (multivariate hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.06-1.83) and those taking antidepressants (multivariate HR, 1.25; 95% CI, 0.99-1.58) had increases in the risks for any nonspine fractures. Women taking tricyclic antidepressants and those using selective serotonin reuptake inhibitors (SSRIs) had similar fracture rates. There were no independent associations between benzodiazepine use or anticonvulsant use and risk for nonspine fracture. Women taking antidepressants compared with nonusers had a 1.7-fold increase in the risk for hip fracture (multivariate HR, 1.65; 95% CI, 1.05-2.57). We did not observe independent associations between use of any of the other 3 classes of CNS active medications and risk of hip fracture.
CONCLUSIONS: Community-dwelling older women taking narcotics have an increased risk for any nonspine fracture, and those taking antidepressants have a greater risk for nonspine fractures, including hip fracture. Rates of fracture were similar in women taking tricyclic antidepressants and those using SSRIs. Benzodiazepine use and anticonvulsant use were not independently associated with an increased risk of nonspine fractures, including hip fracture.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719205     DOI: 10.1001/archinte.163.8.949

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  92 in total

1.  Exposure to medicines among patients admitted for hip fracture and the case-fatality rate at 1 year: a longitudinal study.

Authors:  A Agustí; E Pagès; A Cuxart; E Ballarín; X Vidal; J Teixidor; J Tomás; M M Villar; J-R Laporte
Journal:  Eur J Clin Pharmacol       Date:  2012-04-15       Impact factor: 2.953

2.  The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease.

Authors:  P B Rosenberg; M M Mielke; D Han; J S Leoutsakos; C G Lyketsos; P V Rabins; P P Zandi; J C S Breitner; M C Norton; K A Welsh-Bohmer; I H Zuckerman; G B Rattinger; R C Green; C Corcoran; J T Tschanz
Journal:  Int J Geriatr Psychiatry       Date:  2012-02-29       Impact factor: 3.485

3.  Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them.

Authors:  M Cary Reid; David A Bennett; Wen G Chen; Basil A Eldadah; John T Farrar; Bruce Ferrell; Rollin M Gallagher; Joseph T Hanlon; Keela Herr; Susan D Horn; Charles E Inturrisi; Salma Lemtouni; Yu Woody Lin; Kaleb Michaud; R Sean Morrison; Tuhina Neogi; Linda L Porter; Daniel H Solomon; Michael Von Korff; Karen Weiss; James Witter; Kevin L Zacharoff
Journal:  Pain Med       Date:  2011-08-11       Impact factor: 3.750

4.  Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.

Authors:  Kathleen W Saunders; Michael Von Korff; Cynthia I Campbell; Caleb J Banta-Green; Mark D Sullivan; Joseph O Merrill; Constance Weisner
Journal:  J Pain       Date:  2012-01-29       Impact factor: 5.820

Review 5.  Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding.

Authors:  Sharon-Lise T Normand; Kathy Sykora; Ping Li; Muhammad Mamdani; Paula A Rochon; Geoffrey M Anderson
Journal:  BMJ       Date:  2005-04-30

Review 6.  Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding.

Authors:  Muhammad Mamdani; Kathy Sykora; Ping Li; Sharon-Lise T Normand; David L Streiner; Peter C Austin; Paula A Rochon; Geoffrey M Anderson
Journal:  BMJ       Date:  2005-04-23

7.  Psychotropic medications and the risk of fracture: a meta-analysis.

Authors:  Bahi Takkouche; Agustín Montes-Martínez; Sudeep S Gill; Mahyar Etminan
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Depression and osteoporosis: epidemiology and potential mediating pathways.

Authors:  B Mezuk; W W Eaton; S H Golden
Journal:  Osteoporos Int       Date:  2007-09-01       Impact factor: 4.507

9.  Use of anti-depressants and the risk of fracture of the hip or femur.

Authors:  M W M van den Brand; S Pouwels; M M Samson; T P van Staa; B Thio; C Cooper; H G M Leufkens; A C G Egberts; H J J Verhaar; F de Vries
Journal:  Osteoporos Int       Date:  2009-02-24       Impact factor: 4.507

10.  Patterns and correlates of benzodiazepine use in the French general population.

Authors:  Rajaa Lagnaoui; Fanny Depont; Annie Fourrier; Abdelillah Abouelfath; Bernard Bégaud; Hélène Verdoux; Nicholas Moore
Journal:  Eur J Clin Pharmacol       Date:  2004-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.